Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ADGRL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SH3D21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLA2G1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EPN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YTHDC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
ZNF425 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OAS3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DHRS3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYH2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF79 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC6A6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERVH48-1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC100128198 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
RIPPLY2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on